B. Riley has reduced its price target for Compass Diversified (CDI) from $13 to $8, signaling a more cautious stance on the industrial and consumer-focused holding company. The move reflects a revised assessment of near-term earnings and sector dynamics.
- Price target for CDI reduced from $13 to $8 by B. Riley
- CDI’s year-over-year revenue growth slowed to 2.1% in Q4 2025
- CBOE Volatility Index (VIX) rose to 21.7 by March 4, 2026
- Consensus analyst target for CDI now stands at $10.25
- CDI stock trading at $8.40 as of March 4, 2026
- Downgrade reflects sector-wide caution, not new company-specific data
B. Riley has updated its investment thesis on Compass Diversified (CDI), lowering the price target to $8 from $13, marking a 38.5% reduction in valuation expectations. The adjustment comes without new financial disclosures from CDI, suggesting the change is driven by macroeconomic reassessment rather than company-specific fundamentals. The downgrade underscores growing skepticism around the performance of CDI’s portfolio, which includes businesses in industrial manufacturing and consumer goods. While CDI has maintained stable cash flow in recent quarters, the firm’s revenue growth has slowed to 2.1% year-over-year in Q4 2025, below prior estimates. This deceleration aligns with broader softening in mid-sized industrial demand and consumer discretionary spending. Market indicators show increasing volatility, with the CBOE Volatility Index (VIX) trading at 21.7 as of March 4, 2026, up from 16.4 in January. This environment has prompted analysts to reassess risk exposure in mid-cap industrial equities, contributing to the downward revision. CDI’s stock price, currently trading at $8.40, reflects modest investor caution, though not significant downward momentum. Investors in CDI may reassess exposure to cyclical segments within the company’s portfolio. The adjustment affects analysts’ consensus target, which now stands at $10.25, down 17.4% from its previous average. While the downgrade is not indicative of a fundamental deterioration, it signals a broader reevaluation of leverage, margin stability, and capital deployment efficiency.